OTEZLA Trademark

Trademark Overview

On Thursday, August 16, 2012, a trademark application was filed for OTEZLA with the United States Patent and Trademark Office. The USPTO has given the OTEZLA trademark a serial number of 85705380. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, November 1, 2023. This trademark is owned by Celgene Corporation. The OTEZLA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain blood diseases and cancers
otezla

General Information

Serial Number85705380
Word MarkOTEZLA
Filing DateThursday, August 16, 2012
Status800 - REGISTERED AND RENEWED
Status DateWednesday, November 1, 2023
Registration Number4331247
Registration DateTuesday, May 7, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 19, 2013

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain blood diseases and cancers

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 23, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAMGEN INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799
Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Monday, September 24, 2012NON-FINAL ACTION WRITTEN
Monday, August 20, 2012NEW APPLICATION ENTERED
Thursday, August 23, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 24, 2012ASSIGNED TO EXAMINER
Monday, September 24, 2012NON-FINAL ACTION E-MAILED
Monday, September 24, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 25, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 25, 2012PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, September 25, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 3, 2012ASSIGNED TO LIE
Thursday, November 8, 2012FINAL REFUSAL WRITTEN
Thursday, November 8, 2012FINAL REFUSAL E-MAILED
Thursday, November 8, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, December 13, 2012TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, December 19, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 19, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 19, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 19, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 16, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 30, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 19, 2013PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 7, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, May 7, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sunday, May 20, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 21, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, May 21, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, June 28, 2019NOTICE OF SUIT
Wednesday, April 22, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, May 27, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 27, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 27, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 19, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Saturday, May 7, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, May 5, 2023TEAS SECTION 8 & 9 RECEIVED
Wednesday, November 1, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 1, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, November 1, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, November 1, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, February 25, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 25, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 25, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 25, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 25, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

otezla pharmaceutical preparations certain treatment diseases cancers system blood modulate namely